Cargando…
Vernodalol mediates antitumor effects in acute promyelocytic leukemia cells
Acute promyelocytic leukemia (APL) remains a challenge to cure due to the side effects of cytotoxic chemotherapy and drug resistance. The present study demonstrated that vernodalol, an active compound isolated from Centratherum anthelminticum, suppresses APL cell proliferation and induces cell cycle...
Autores principales: | Wu, Wenjun, Han, Xiaoyan, Wu, Cai, Wei, Guoqing, Zheng, Gaofeng, Li, Yi, Yang, Yang, Yang, Li, He, Donghua, Zhao, Yi, Cai, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776941/ https://www.ncbi.nlm.nih.gov/pubmed/29434929 http://dx.doi.org/10.3892/ol.2017.7544 |
Ejemplares similares
-
Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration
por: Han, Xiaoyan, et al.
Publicado: (2021) -
Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report
por: Yan, Haimeng, et al.
Publicado: (2021) -
Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients
por: Yue, Xiaoyan, et al.
Publicado: (2022) -
Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data
por: He, Jingsong, et al.
Publicado: (2020) -
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
por: Yang, Li, et al.
Publicado: (2018)